Monkeypox in a renal transplant recipient: is it a hazard for immunocompromised patients?
  • Farah Heis
    Rutgers Health/Monmouth Medical Center, New Jersey, USA
  • Mohamed Heis
    Faculty of Medicine, Yarmouk University, Irbid, Jordan
  • Mahrukh Khan
    Rutgers Health/Monmouth Medical Center, New Jersey, USA
  • Manjula Ashok
    Rutgers Health/Monmouth Medical Center, New Jersey, USA

Keywords

Monkeypox, renal transplant recipient, sexually transmitted disease

Abstract

There has been a recent outbreak of monkeypox in the United States, mostly among men who have sex with men (MSM). It seems to be a self-limiting disease but can be potentially serious in immunocompromised patients. Monkeypox infection is transmitted mainly through skin-to-skin contact and possibly seminal and vaginal fluids. Very few cases of monkeypox infection in immunocompromised patients have been published in the literature. We report a case of infection in a renal transplant recipient, and describe the clinical course and outcome.

VIEW THE ENTIRE ARTICLE

References

  • Centers for Disease Control and Prevention. Mpox. Available from https://www.cdc.gov/poxvirus/mpox/index.html (accessed 30 March 2023)
  • Yinka-Ogunleye A, Aruna O, Dalhat M, et al. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis 2019;19:872-879.
  • Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. N Engl J Med 2022;387:e69
  • Attieh RM, Brumble L, Elwasila SM, Wadei HM. Disseminated Monkeypox Infection in a Kidney Transplant Recipient: A Case Report. Transplant Proc 2023;55:667-671.
  • Ogoina D, Iroezindu M, James HI, et al. Clinical Course and Outcome of Human Monkeypox in Nigeria. Clin Infect Dis 2020;71:e210-e214.
  • Views: 327
    HTML downloads: 53
    PDF downloads: 309


    Published: 2023-05-09
    Issue: 2023: Vol 10 No 6 (view)


    How to cite:
    1.
    Heis F, Heis M, Khan M, Ashok M. Monkeypox in a renal transplant recipient: is it a hazard for immunocompromised patients?. EJCRIM 2023;10 doi:10.12890/2023_003857.

    Most read articles by the same author(s)